Status:
COMPLETED
1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Refractive Ametropia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Experienced soft contact lens wearing subjects will be enrolled in this 1-week, post-market, bilateral, repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit ...
Eligibility Criteria
Inclusion
- Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent.
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- Have no active ocular disease or allergic conjunctivitis.
- Not be using any topical ocular medications.
- Be willing and able to follow instructions.
- Have signed a statement of informed consent
Exclusion
- Participating in a conflicting study in the opinion of the Investigator.
- Considered by the Investigator to not be a suitable candidate for participation.
Key Trial Info
Start Date :
October 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 15 2023
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT06053736
Start Date
October 4 2023
End Date
December 15 2023
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bausch & Lomb, Incorporated
Rochester, New York, United States, 14609